Overview

Reliability, Safety and Usability of the Transplantation Sensor System Combined With Myfortic® in Adult Kidney Transplant Patients

Status:
Completed

Trial end date:
2011-11-18

Target enrollment:

Participant gender:

Summary

The main purpose of this exploratory trial is to evaluate the reliability, safety and usability of the Transplantation Sensor System when the Ingestible Event Marker (IEM) is given in combination with ECMPS 360 mg tablets in adult renal transplant recipients.

Phase:

Phase 2

Details

Lead Sponsor:

Novartis Pharmaceuticals

Collaborators:

Proteus Digital Health, Inc.
Quintiles, Inc.

Treatments:

Mycophenolate mofetil